Contact arGentis Pharmaceuticals, LLC

Name: *

Email: *Check here to receive email updates

Subject: *

Message: *

What is Scleroderma?

Contact Us

Argentis Pharmaceuticals, LLC

1016 W. Poplar Ave., Suite 106-238 Collierville TN 38017 US

+1 (901) 881-8665

About Us

arGentis™ Pharmaceuticals, LLC is a private TN based pharmaceutical company with a mid-stage Orphan Drug treatment (ARG201) for late stage diffuse systemic scleroderma (dcSSc). The company is seeking capital or a partner to complete a Pivotal Clinical Trial which will enable obtaining marketing approval in the EU.

The Company has a genotype marker (ROT1) that predicts patient response to treatment by oral tolerance for treatments like ARG201 for dcSSc.

arGentis™ also has a treatment for Rheumatoid arthritis (ARG301) that has completed a Phase I Clinical Trial in the US.